Njeri Maina

Njeri Maina, M.D., Ph.D.

Douglasville

Monday, Tuesday, Wednesday, Thursday
770.942.7696
4645 Timber Ridge Drive
Suite 160
Douglasville, GA 30135

Dr. Njeri Maina is a Board Certified Allergist & Immunologist who completed her Allergy and Immunology fellowship at the University of Alabama in Birmingham and her residency at Vanderbilt University Medical Center in Nashville. She received her medical degree, along with her Ph.D. in Microbiology and Immunology, from Indiana University School of Medicine.

Her international experience includes medicine rotations at Georgetown Public Hospital Corporation in Guyana, San Vito in Costa Rica, and Moi University Teaching and Referral Hospital in Kenya.

Dr. Maina’s years of experience, in the U.S and abroad, has given her a unique perspective on the needs of the patients she treats. She finds educating her patients on their diagnosis, providing information on their condition, and detailing the treatment options, to be extremely important in providing excellent care to the patient as well as those participating in their care.

Dr. Maina is a Fellow in the American College of Allergy, Asthma, and Immunology and has served in several areas including the Leadership Committee, the Population Health Committee, and Infectious Diseases & International Travel Committee. She is a Fellow in the American Academy of Allergy, Asthma, and Immunology and was a member of the Committee on the Underserved. During her time in Alabama, Dr. Maina served as an allergist at the Birmingham Veterans Administration and was a volunteer Clinical Assistant Professor, Department of Pediatrics, Division of Allergy and Immunology at the University of Alabama at Birmingham.

Dr. Maina has been in practice in Birmingham, Alabama since 2018. She joined Atlanta Allergy & Asthma in early 2023 and will see patients in the Douglasville office.

Dr. Maina, along with her husband and children, live in Douglasville, GA.

Publications

  • Anderson, J and Maina, N. Reviewing clinical considerations and guideline recommendations of C1 inhibitor prophylaxis for hereditary angioedema. Clinical and Translational Allergy. January 2022; e12092
  • Paige D, Maina, N, Anderson JT. Hereditary angioedema: Comprehensive management plans and patient support. Allergy Asthma Proc. 2020 Nov 1;41(Suppl 1):S38-S42.
  • Hough, K, Wilson, L, Trevor, J, Strenkowski, J, Maina, N, Kim, Y, Spell, M, Wang, Y, Chanda, D, Rodriguez , J Dager, Sharma, N, Curtiss, M, Antony, V, Dransfield, M, Chaplin, D, Steele, C, Barnes, S, Duncan, S, Prasain, J , Thannickal, V, and Deshane, J. Unique Lipid Signatures of Extracellular Vesicles from the Airways of Asthmatics. Scientific Reports (2018) 8:10340.
  • Maina N, Zhong L, Li X, Zhao W, Han Z, Bischof D, Aslanidi G, Zolotukhin S, Weigel-Van Aken KA, Rivers AE, Slayton WB, Yoder MC, Srivastava A. (2008). Optimization of recombinant adeno-associated viral vectors for human beta-globin gene transfer and transgene expression. Human Gene Therapy, 19: 365-75.
  • Maina N, Han Z, Li X, Hu Z, Zhong L, Bischof D, Weigel-Van Aken KA, Slayton WB, Yoder MC, Srivastava A. (2008). Recombinant self-complementary adeno-associated virus serotype vector-mediated hematopoietic stem cell transduction and lineage-restricted, long-term transgene expression in a murine serial bone marrow transplantation model. Human Gene Therapy, 19: 376-83.
  • Han Z, Berendzen K, Zhong L, Surolia I, Chouthai N, Zhao W, Maina N, Srivastava A, Stacpoole PW. (2008). A combined therapeutic approach for pyruvate dehydrogenase deficiency using self-complementary adeno-associated virus serotype-specific vectors and dichloroacetate. Mol Genet Metab. 93: 381-7.
  • Han Z, Zhong L, Maina N, Hu Z, Li X, Chouthai NS, Bischof D, Weigel-Van Aken KA, Slayton WB, Yoder MC, Srivastava A. (2008). Stable integration of recombinant adeno-associated virus vector genomes after transduction of murine hematopoietic stem cells. Human Gene Therapy, 19: 267-78.
  • Zhong L, Li W, Li Y, Zhao W, Wu J, Li B, Maina N, Bischof D, Qing K, Weigel-Kelley KA, Zolotukhin I, Warrington KH Jr, Li X, Slayton WB, Yoder MC, Srivastava A. (2006). Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5. Human Gene Therapy, 17: 321-33.
  • Zhong L, Zhao W, Wu J, Maina N, Han Z and Srivastava A. (2006). Adeno-associated virus-mediated gene transfer in hematopoietic stem/progenitor cells as a therapeutic tool. Current Gene Therapy, 6: 683-98.
  • Zhong L, Li W, Yang Z, Qing K, Tan M, Hansen J, Li Y, Chen L, Chan RJ, Bischof D, Maina N, Weigel-Kelley KA, Zhao W, Larsen SH, Yoder MC, Shou W, Srivastava A. (2004). Impaired nuclear transport and uncoating limit recombinant adeno-associated virus 2 vector-mediated transduction of primary murine hematopoietic cells. Human Gene Therapy, 15: 1207-18.
  • Khalaf W, Maina C, Byers J, Harvey W. (2002). Interferon-alpha 2b and vesnarinone influence levels of tumor necrosis factor-alpha, apoptosis, or interleukin 6 in ESKOL, a hairy cell leukemic cell line. A potential cytokine and oncogene relationship regulating apoptosis is suggested. Leukemia Research, 26: 407-8.

Presentations & Abstracts

  • Maina, N, Atkinson, P, Kankirawatana, S. Heterozygous pathogenic TNFRSF13B (TACI) variant in a patient with pediatric onset, difficult-to-treat inflammatory bowel disease. CIS Annual Meeting Toronto, Canada, April 2018
  • Maina, N, Kankirawatana, S. A Case Report of a Probable Exercise-dependent Etanercept Induced Type I mediated Allergic Reaction. ACAAI Annual Meeting, San Francisco, CA, November 2016
  • Hough, K.P., Wilson, L., Strenkowski, J.G., Maina, N, Spell, M.L., Rodriguez Dager, J., Trevor, J.L., Wang, Y., Kim, Y., Chanda, D., Sharma, N., Antony, V., Dransfield, M.T., Steele, C., Duncan, S.R., Prasain, J.K., Barnes, S., Chaplin, D.D., Thannickal, V.J., and Deshane, J.S. Lipidomic Profiling of Airway Exosomes from Asthmatics Reveals Increased Phosphatidylcholine, Lyso-Phosphatidylcholine and Sphingomyelins. Poster Discussion, A28. Exosomes and MicroRNA, American Thoracic Society, Washington D.C. April 2017.
  • Hough, K.P., Wilson, L., Strenkowski, J.G., Maina, N, Spell, M.L., Rodriguez Dager, J., Trevor, J.L., Wang, Y., Kim, Y., Chanda, D., Sharma, N., Antony, V., Dransfield, M.T., Steele, C., Duncan, S.R., Prasain, J.K., Barnes, S., Chaplin, D.D., Thannickal, V.J., and Deshane, J.S. Airway Exosomes from Asthmatics Modulate Differential T Helper Responses. Pulmonary & Critical Care Update, University of Alabama at Birmingham, Birmingham, AL. April 2017.
  • Maina N, Zhong Li, Li X, Zhao W, Han Z, Bischof B, Aslanidi G, Zolotukhin Z, Weigel-Van Aken K, Rivers A, Slayton W, Yoder M, Srivastava A. Optimization of recombinant adeno-associated virus vectors for human β-globin gene transfer and transgene expression. American Society of Gene Therapy, May 2008, Boston, Massachusetts.
  • Han Z, Zhong L, Maina N, Hu Z, Li X, Chouthai, N, Bischof D, Weigel-Van Aken K, Slayton W, Yoder M, Srivastava A. Recombinant adeno-associated virus 2 vector genomes are stably integrated into chromosomes following transduction of murine hematopoietic stem cells. American Society of Gene Therapy, May 2008, Boston, Massachusetts.
  • Han Z, Berendzen K, Zhong L, Chouthai N, Zhao W, Maina N, Srivastava A, Stacpoole P. Optimization of delivery and expression of the pyruvate dehydrogenase E1 alpha subunit gene using self-complementary adeno-associated virus serotype vectors. American Society of Gene Therapy, May 2007, Seattle, Washington.
  • Maina N, Han Z, Li X, Zhao W, Zhong L, Hu Z, Ma W, Slayton W, Srivastava A . Strategies for improving adeno-associated virus vector-mediated gene transfer in primary murine hematopoietic stem cells in vivo. American Society of Gene Therapy, May 2007, Seattle, Washington.
  • Maina N, Zhao W, Li X, Han Z, Zhong L, Aslanidi G, Zolotukhin S, Slayton W, Srivastava A. Adeno-associated virus-mediated gene transfer: The combined use of self-complementary AAV vectors and the parvovirus B19 promoter leads to expression of therapeutic levels of the human beta-globin gene. American Society of Gene Therapy, May 2007, Seattle, Washington.
  • Maina N, Zhong L, Zhao W, Aslanidi G, Zolotukhin S, and Srivastava, A . AAV-mediated β-globin gene transfer: The combined use of self-complementary vectors and the parvovirus B19p6 promoter significantly augments transgene expression. Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases, November 2006, Sonoma, California.